Evidence map›Paper›PMID 38136941›Full record

ArticleGenes2023

An Artificial Intelligence Prediction Model of Insulin Sensitivity, Insulin Resistance, and Diabetes Using Genes Obtained through Differential Expression.

Jesús María González-Martín, Laura B Torres-Mata, Sara Cazorla-Rivero, Cristina Fernández-Santana, Estrella Gómez-Bentolila, Bernardino Clavo, Francisco Rodríguez-Esparragón

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jesús María González-MartínResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.
Laura B Torres-MataResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.ORCID 0000-0003-3304-4176
Sara Cazorla-RiveroResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.
Cristina Fernández-SantanaResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.
Estrella Gómez-BentolilaResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.
Bernardino ClavoResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.ORCID 0000-0003-2522-1064
Francisco Rodríguez-EsparragónResearch Unit, Hospital Universitario de Gran Canaria Doctor Negrín, 35019 Las Palmas, Spain.ORCID 0000-0003-1663-3673
Hospital Universitario de Gran Canaria Doctor Negrín · ESInstituto de Salud Carlos III · ESUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin is a powerful pleiotropic hormone that affects processes such as cell growth, energy expenditure, and carbohydrate, lipid, and protein metabolism. The molecular mechanisms by which insulin regulates muscle metabolism and the underlying defects that cause insulin resistance have not been fully elucidated. This study aimed to perform a microarray data analysis to find differentially expressed genes. The analysis has been based on the data of a study deposited in Gene Expression Omnibus (GEO) with the identifier "GSE22309". The selected data contain samples from three types of patients after taking insulin treatment: patients with diabetes (DB), patients with insulin sensitivity (IS), and patients with insulin resistance (IR). Through an analysis of omics data, 20 genes were found to be differentially expressed (DEG) between the three possible comparisons obtained (DB vs. IS, DB vs. IR, and IS vs. IR); these data sets have been used to develop predictive models through machine learning (ML) techniques to classify patients with respect to the three categories mentioned previously. All the ML techniques present an accuracy superior to 80%, reaching almost 90% when unifying IR and DB categories.

Indexed as

Diabetes MellitusInsulin ResistanceArtificial IntelligenceHumansInsulinMicroarray AnalysisInsulinexpression estimationmachine learningmicroarraypathway analysis

Identifiers

PMID38136941
PMCPMC10743311
OpenAlexW4388939048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.